Humira Buyers Take AbbVie Antitrust Challenge To 7th Circ.
Humira buyers are appealing to the Seventh Circuit an Illinois federal judge's dismissal of their proposed class action claiming AbbVie Inc. built a "patent thicket" around the immunosuppressant drug to block...To view the full article, register now.
Already a subscriber? Click here to view full article